At Inotiv, you have access to specialized in vivo models to help you drive your program forward. Our goal is to provide you with preclinical (efficacy and toxicity) data to support the advancement of your biologic and small molecule from discovery to First-in-Human. We work with you to customize your study design to effectively reach your project’s goal. If you do not see a capability you need listed below, please contact us as we are continuously developing new models.
Our capabilities include the following:
- In vitro services
- Ex vivo analysis
- Pathology services
- In vivo research of specific toxicology, pharmacokinetic, and pharmacological models
- Established pharmacology models
- PK/TK modeling and simulation
Established Pharmacology and Toxicology Models
Access a wide range of in vivo preclinical early-stage research, efficacy, pharmacology, and safety studies. Our experienced staff has the expertise to offer a wide range of study designs in pharmacology, toxicology, inflammatory bowel disease, and immunologic models. Our hands-on collaborative approach means that our scientists will work with you to learn your specific preclinical study requirements and assist you from initial study design to final reporting with dependable, reproducible results.